Effect of delivery on anal sphincter morphology and function.
J Zetterström, A Mellgren, L L Jensen...
https://pubmed.ncbi.nlm.nih.gov/10528760/Actively Recruiting
Led by State Scientific Centre of Coloproctology, Russian Federation · Updated on 2022-01-27
340
Participants Needed
7
Research Sites
8 weeks
Total Duration
Researchers are evaluating the efficacy and safety of treating chronic anal fissure, a painful rupture in the anal canal lasting over two months and resistant to non-surgical treatments. The study compares two treatment approaches botulinum toxin injections and lateral subcutaneous sphincterotomy surgery. The condition mainly affects younger and working-age adults and involves internal sphincter muscle spasm as a key factor. One treatment group receives complex therapy including surgical removal of the fissure without cutting the internal sphincter, followed by injections of Botulinum Toxin Type A directly into the internal anal sphincter at four points. The other group undergoes lateral subcutaneous sphincterotomy, where the internal sphincter muscle is partially cut using a scalpel under anesthesia. Both procedures are performed under spinal anesthesia in a surgical setting. Participants will be monitored for up to 60 days after treatment. Researchers will assess anal sphincter insufficiency, pain intensity at multiple time points, wound healing, sphincter muscle function, temporary disability, and recurrence of the fissure. The study aims to understand differences in treatment effects, including frequency and duration of post-operative incontinence, by comparing these two approaches for chronic anal fissure.
CONDITIONS
Complex Treatment of a Chronic Anal Fissure
E
Evgeny E. Zharkov, MD
R
Roman Yu. Khryukin, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
State Scientific Centre of Coloproctology, Russian Federation
Lead Sponsor
St. Petersburg State Pavlov Medical University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 60 days
Participants receive complex treatment for chronic anal fissure either through Botulinum Toxin Type A injections following fissure excision or lateral subcutaneous sphincterotomy surgery.
Visits on day 7, 30, and 60 for assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
J Zetterström, A Mellgren, L L Jensen...
https://pubmed.ncbi.nlm.nih.gov/10528760/Maged Nasr, Hussin Ezzat, Magdy Elsebae
https://pubmed.ncbi.nlm.nih.gov/20703472/D Gui, E Cassetta, G Anastasio...
https://pubmed.ncbi.nlm.nih.gov/7934496/Richard L Nelson, Kathryn Thomas, Jenna Morgan...
https://pubmed.ncbi.nlm.nih.gov/22336789/P Delechenaut, A M Leroi, J Weber...
https://pubmed.ncbi.nlm.nih.gov/1511644/H-L Chen, X-B Woo, H-S Wang...
https://pubmed.ncbi.nlm.nih.gov/24500725/J M Jorge, S D Wexner
https://pubmed.ncbi.nlm.nih.gov/8416784/J J Tjandra, W R Han, B S Ooi...
https://pubmed.ncbi.nlm.nih.gov/11552935/Harish Iswariah, Jacqueline Stephens, Nicholas Rieger...
https://pubmed.ncbi.nlm.nih.gov/15972045/A H Sultan, M A Kamm, C N Hudson...
https://pubmed.ncbi.nlm.nih.gov/8247054/State Scientific Centre of Coloproctology, Russian Federation
Lead Sponsor
St. Petersburg State Pavlov Medical University
Collaborating Sponsor